RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
  Clinical Trials
   Pulmonary Hypertension
  Myocardial Infarction
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Hypertension Channel

subscribe to Hypertension newsletter
Latest Research : Cardiology : Hypertension

   EMAIL   |   PRINT
BHF comments on ASCOT trial results

Sep 6, 2005 - 1:22:00 AM
"This is an important study because it provides evidence on the efficacy of the newer blood pressure lowering agents at reducing the risk of a heart attack or stroke"

[RxPG] The British Heart Foundation has commented on the results of the ASCOT trials, which have been presented at the European Society of Cardiology Congress 2005 in Stockholm.

The trials have revealed that new classes of blood pressure-lowering drugs could save lives by preventing strokes and heart attacks even more effectively.

Professor Peter Weissberg, Medical Director of the British Heart Foundation, said:

"This is an important study because it provides evidence on the efficacy of the newer blood pressure lowering agents at reducing the risk of a heart attack or stroke.

"We have known for some time that they are effective at lowering blood pressure but this new study shows that they are even better at preventing heart attacks and strokes than the blood pressure lowering drugs we have been using for many years.

"In addition, when these drugs are combined with atorvastatin, a commonly prescribed lipid lowering drug, they are even more effective.

"The guidelines for treatment of high blood pressure are constantly being revised in the light of results of new clinical trials like this one. We expect that this study will have a major influence on future guidelines published by organisations such as NICE and consequently on future prescribing of antihypertensive drugs.

"However, people taking the older types of drug should however, be reassured that they are on effective treatment and there may be good medical reasons why they should continue on these drugs, rather than swap to the newer ones.

"The results of this trial serve to re-emphasise just how important it is to reducing blood pressure and cholesterol in patients at risk of a heart attack or stroke."

Publication: British Heart Foundation
On the web: British Heart Foundation 

Advertise in this space for $10 per month. Contact us today.

Related Hypertension News
Osmoreceptors in liver help increase blood pressure
Renal sympathetic nerve ablation may cure high blood pressure
Kids with hypertension more likely to fumble in studies
Need for a revamp of hypertension treatment
Scientists switch off nerves to treat high blood pressure
Low potassium levels likely to trigger high blood pressure
BP response to stress can point to better treatment
Statins may help lower blood pressure
Now a new way to regulate blood pressure
Posture linked to blood pressure

Subscribe to Hypertension Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)